"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"
NCT00365846
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Renal Transplant
Interventions
DRUG:
Campath-1H
Sponsor
University of Wisconsin, Madison